Inferential statistics and false conclusions: is the p value to blame?
Significance testing and p values are widely used in medical publications, but just how meaningful are they?
Celebrate MedComms Day 2018!
Add your contributions to the 7th annual MedComms Day.
Meeting report: summary of the 14th Annual Meeting of ISMPP – Part 2
Missed the 14th Annual Meeting of ISMPP? Read the second part of our meeting report to get up to speed!
Meeting report: summary of the 14th Annual Meeting of ISMPP — Part 1
Missed the 14th Annual Meeting of ISMPP? Read our meeting report to get up to speed!
The disparity between top-tier journals and their smaller counterparts: should we be worried?
In a recent opinion piece for The BMJ, Dr Elizabeth Loder describes the potential impact of the resource gap between top- and lower-tier journals.
Clinical trial transparency: are non-commercial funders lagging behind industry sponsors?
A new study from the AllTrials team sheds light on clinical trial reporting rates by non-industry sponsors.
The end of a successful “pilot”: GAPP retires after 6 years
The GAPP team retires after six years of “providing a timely and credible response to influential stories about medical publication professionals”.
ResearchGate and publishers collaborate over copyright
As discussions continue on how best to balance open science with copyright protection, ResearchGate and publishers collaborate on the issue.
Inconsistency in retraction notices across bibliographic platforms
A recent study highlights the difficulty in identifying retracted articles in online databases.
How to get your clinical research published in a high-tier journal
In the latest issue of The Map Newsletter from ISMPP, medical communications professionals share their experience and tips on how to get clinical research published in high-tier journals.
No improvement in reporting of non-pharmacological interventions in 13 years
The CONSORT extension for reporting non-pharmacological interventions was introduced in 2008. A recent study looks at the impact of this guidance on reporting standards.
Bronze beats gold in open access: implications for data re-use
A study finds that the most common form of open access is ‘bronze’, meaning that data are free to read but not re-use. This is likely to have negative implications for research.
Focusing on big data: is seeing believing?
Are we too willing to accept big data as fact? Find out how scientific publishing can learn from common mistakes arising from bad data practice.
When will open access be fully achieved?
Open access publishing is becoming increasingly prevalent, but how long until all publications are open access? A multi-database study (Crossref, Web of Science and Unpaywall), by Piwowar et al predicts that open access will become the future publication standard, and estimates the date at which all research will become freely accessible.
PubMed Commons now discontinued
As PubMed Commons closes due to lack of use, what does this tell us about engagement with medical publications and post-publication peer review?
Cutting-Edge Themes Draw Attendees to 14th Annual Meeting of ISMPP
Online Registration Until April 10, 2018! Both seasoned publication professionals and those newer to the profession will benefit from the cutting-edge themes at the 14th Annual Meeting of the International … Continue Reading Cutting-Edge Themes Draw Attendees to 14th Annual Meeting of ISMPP